Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

EFPIA looks to ABPI for comms director

Andrew Powrie-Smith will join EU pharma trade body in New Year

- PMLiVE

Otsuka expands CNS presence with Avanir purchase

Deal for US biotech is valued at $3.5bn

- PMLiVE

Excellence in pharma launches

Maximising your chances of success - some food for thought

- PMLiVE

Bayer photo contest to raise awareness of blood clot

Public invited to submit photos that take their breath away

Sanofi reception

Sanofi’s Priftin cleared for latent tuberculosis in the US

FDA approves Priftin with isoniazid for patients aged two years and older

- PMLiVE

UCB partners with Daiichi to bring epilepsy drug to Japan

Companies partner on expanding market for Vimpat

- PMLiVE

NICE backtracks on Gazyvaro rejection

Roche agrees to patient access scheme to help gain leukaemia recommendation

- PMLiVE

GSK names drug hunter challenge winners

Competition finds promising projects in anti-infectives, cancer and neurodegenerative diseases

- PMLiVE

GSK’s oncology president joins NuCana board

Paolo Paoletti also has experience in cancer research at Lilly

- PMLiVE

Building a business that is lean and specialised

Tuomo Pätsi on Celgene’s approach to access, marketing and the importance of culture

- PMLiVE

Merck: You need to win locally in consumer health

And company says it would consider targeted 'bolt-on' acquisitions

- PMLiVE

Succinct and ecancer team up on oncology education events

Will work together to support HCPs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links